Ann Geriatr Med Res > Volume 28(2); 2024 > Article |
|
AUTHOR CONTRIBUTIONS
Conceptualization, AZ, JFP, FMRC; Investigation, AZ, RPV, KCC, RCC, DCM, PGR, WGB; Methodology, AZ, RPV; Formal analysis, AZ, RPV; Data Curation, AZ, RPV, KCC, RCC, DCM, PGR, WGB; Writing–original draft, AZ, RPV, KCC, RCC, DCM, PGR, WGB, JFP, FMRC; Writing–review & editing, AZ, RPV, KCC, RCC, DCM, PGR, WGB, JFP, FMRC; Visualization, AZ, JFP, FMRC; Project administration, AZ, JFP, FMRC; Resources, JFP, FMRC; Supervision, JFP, FMRC.
DATA AVAILABILITY
Data are available at the following link: https://osf.io/df7tn/files/osfstorage?view_only=.
Variable | Symmetry (n=372) | Asymmetry (n=1,096) | p-value |
---|---|---|---|
Multimorbidity | <0.05* | ||
<2 | 35 (35.00) | 65 (65.00) | |
≥2 | 337 (24.63) | 1,031 (75.37) | |
Calf circumference (cm) | <0.05* | ||
Normal muscle mass | 143 (29.24) | 346 (70.76) | |
Reduced muscle mass | 229 (23.39) | 750 (76.61) | |
Polypharmacy (drugs) | <0.05* | ||
0–4 | 235 (22.36) | 816 (77.64) | |
≥5 | 137 (32.85) | 280 (67.15) | |
Age (y) | 0.347 | ||
60–79 | 199 (24.39) | 617 (75.61) | |
≥80 | 173 (26.53) | 479 (73.47) | |
Sex | 0.599 | ||
Male | 223 (25.84) | 640 (74.16) | |
Female | 149 (24.63) | 456 (75.37) | |
BMI (kg/m2) | 0.572 | ||
<30 | 304 (25.65) | 881 (74.35) | |
≥30 | 68 (24.03) | 215 (75.97) | |
PASE (points) | 0.417 | ||
No sedentarism | 197 (24.50) | 607 (75.50) | |
Sedentarism | 175 (26.36) | 489 (73.64) | |
SPPB (points) | 0.291 | ||
Unaltered physical performance | 220 (24.39) | 682 (75.61) | |
Altered physical performance | 152 (26.86) | 414 (73.14) | |
Lawton Index (points) | 0.257 | ||
No functional impaired | 139 (23.76) | 446 (76.24) | |
Functional impaired | 233 (26.39) | 650 (73.61) | |
Functional Reach test (cm) | 0.328 | ||
No fall risk | 236 (26.22) | 664 (73.78) | |
Fall risk | 136 (23.94) | 1,096 (76.06) |
Values are presented as number (%).
BMI, body mass index; PASE, Physical Activity Scale for the Elderly; SPPB, Short Physical Performance Battery.
Cutoff values of calf circumference (31 cm), PASE (men 64 points; women 52 points), SPPB (8 points), Lawton index (women 7 points; men 4 points), and Functional reach test (20.32 cm).
Variable |
Crude model |
Adjusted model |
---|---|---|
cPR (95% CI) | aPRa) (95% CI) | |
Calf circumference (cm) | ||
Normal muscle mass | Ref. | Ref. |
Reduced muscle mass | 1.08 (1.01–1.16) | 1.08 (1.01–1.15) |
Functional Reach Test (cm) | ||
No falls risk | Ref. | Ref. |
Falls risk | 1.03 (0.97–1.10) | 1.08 (1.02–1.16) |
Polypharmacy (drugs) | ||
0–4 | Ref. | - |
≥5 | 0.86 (0.80–0.93) | |
Multimorbidity | ||
<2 | Ref. | - |
≥2 | 1.16 (1.01–1.34) | |
Age (y) | ||
60–79 | Ref. | - |
≥80 | 0.97 (0.91–1.03) | |
Sex | ||
Male | Ref. | - |
Female | 1.02 (0.96–1.08) | |
BMI (kg/m2) | ||
<30 | Ref. | - |
≥30 | 1.02 (0.95–1.10) | |
PASE (points) | ||
No sedentarism | Ref. | - |
Sedentarism | 0.98 (0.92–1.04) | |
SPPB (points) | ||
Unaltered physical performance | Ref. | - |
Altered physical performance | 0.96 (0.91–1.03) | |
Lawton Index (points) | ||
No functional impaired | Ref. | Ref. |
Functional impaired | 0.97 (0.91–1.03) | 0.92 (0.84–0.99) |
Variable |
Male |
p-value |
Female |
p-value | ||
---|---|---|---|---|---|---|
Symmetry (n=282) | Asymmetry (n=581) | Symmetry (n=187) | Asymmetry (n=418) | |||
Multimorbidity (%) | <0.05* | 0.304 | ||||
<2 | 23 (37.10) | 39 (62.90) | 12 (31.58) | 26 (68.42) | ||
≥2 | 200 (24.97) | 601 (75.03) | 137 (24.16) | 430 (75.84) | ||
Calf circumference (cm) | <0.05* | 0.229 | ||||
Normal muscle mass | 88 (30.34) | 202 (69.66) | 55 (27.64) | 144 (72.36) | ||
Reduced muscle mass | 135 (23.56) | 438 (76.44) | 94 (23.15) | 312 (76.85) | ||
Polypharmacy (drugs) | <0.05* | 0.161 | ||||
0–4 | 133 (21.80) | 477 (78.20) | 102 (23.13) | 339 (76.87) | ||
≥5 | 90 (35.57) | 163 (64.43) | 47 (28.66) | 117 (71.34) | ||
Functional Reach test (cm) | 0.570 | <0.05* | ||||
No falls risk | 136 (25.19) | 404 (74.81) | 100 (27.78) | 260 (72.22) | ||
Falls risk | 87 (26.93) | 236 (73.07) | 49 (20.00) | 196 (80.00) | ||
Lawton Index (points) | <0.05* | 0.071 | ||||
No functional impaired | 125 (22.85) | 422 (77.15) | 14 (36.84) | 24 (63.16) | ||
Functional impaired | 98 (31.01) | 218 (68.99) | 135 (23.81) | 432 (76.19) | ||
BMI (kg/m2) | 0.361 | 0.824 | ||||
<30 | 183 (26.52) | 507 (73.48) | 121 (24.44) | 374 (75.56) | ||
≥30 | 40 (23.12) | 133 (76.88) | 28 (25.45) | 82 (74.55) | ||
Age (y) | 0.379 | 0.711 | ||||
60–79 | 114 (24.62) | 349 (75.38) | 85 (24.08) | 268 (75.92) | ||
≥80 | 109 (27.25) | 291 (72.75) | 64 (25.40) | 188 (74.60) | ||
PASE (points) | 0.227 | 0.800 | ||||
No sedentarism | 108 (24.11) | 340 (75.89) | 89 (25.00) | 267 (75.00) | ||
Sedentarism | 115 (27.71) | 300 (72.29) | 60 (24.10) | 189 (75.90) | ||
SPPB (points) | 0.912 | 0.127 | ||||
Unaltered physical performance | 136 (25.71) | 393 (74.29) | 84 (22.52) | 289 (77.48) | ||
Altered physical performance | 87 (26.05) | 247 (73.95) | 65 (28.02) | 167 (71.98) |